Potential new roles for glycogen in epilepsy

Area of Science:

• Neuroscience
• Metabolic Research
• Epilepsy Studies

Background:

• Epileptogenic foci often exhibit low glucose metabolism (hypometabolism) on fluorodeoxyglucose-positron emission tomography (FDG-PET) scans between seizures, even without structural abnormalities.
• The underlying cause of this interictal hypometabolism in epilepsy remains unexplained.
• Astrocytes utilize glycogen as an emergency fuel source during high metabolic demand, such as seizures.

Purpose of the Study:

• To review current knowledge on glucose and glycogen metabolism and oxidative stress in epilepsy.
• To propose a new hypothesis explaining interictal hypometabolism in epileptogenic zones.
• To explore potential therapeutic strategies targeting glycogen metabolism for epilepsy treatment.

Main Methods:

• Review of existing literature on glucose and glycogen metabolism in human epilepsy and rodent seizure models.
• Analysis of interictal and ictal metabolic states.
• Formulation of a novel hypothesis based on observed metabolic patterns.

Main Results:

• Interictal brain glucose levels are normal, yet FDG-PET shows hypometabolism.
• Rodent models show decreased brain glycogen during seizures and increased levels post-seizure.
• Epileptic humans and chronic models exhibit normal glucose but elevated interictal glycogen in seizure foci.

Conclusions:

• High interictal brain glycogen in epileptogenic areas may be an adaptive response to support energy demands, leading to decreased glucose utilization and low FDG-PET signals.
• Interictal glycogen depletion could impair astrocyte function (e.g., potassium buffering), potentially promoting seizure generation.
• Therapies supporting glycogen metabolism may offer a novel approach to treating epilepsy.